1. Home
  2. RVSB vs CALC Comparison

RVSB vs CALC Comparison

Compare RVSB & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Riverview Bancorp Inc

RVSB

Riverview Bancorp Inc

HOLD

Current Price

$5.32

Market Cap

110.8M

Sector

Finance

ML Signal

HOLD

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$6.34

Market Cap

91.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVSB
CALC
Founded
1923
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.8M
91.5M
IPO Year
1993
N/A

Fundamental Metrics

Financial Performance
Metric
RVSB
CALC
Price
$5.32
$6.34
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$7.00
$14.50
AVG Volume (30 Days)
45.4K
144.6K
Earning Date
01-29-2026
11-12-2025
Dividend Yield
1.51%
N/A
EPS Growth
361.12
N/A
EPS
0.22
N/A
Revenue
$52,756,000.00
N/A
Revenue This Year
$10.25
N/A
Revenue Next Year
$11.23
N/A
P/E Ratio
$24.09
N/A
Revenue Growth
15.20
N/A
52 Week Low
$4.74
$1.42
52 Week High
$6.59
$6.40

Technical Indicators

Market Signals
Indicator
RVSB
CALC
Relative Strength Index (RSI) 51.06 76.69
Support Level $5.01 $4.64
Resistance Level $5.62 $5.34
Average True Range (ATR) 0.18 0.51
MACD 0.02 0.10
Stochastic Oscillator 50.00 90.04

Price Performance

Historical Comparison
RVSB
CALC

About RVSB Riverview Bancorp Inc

Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

Share on Social Networks: